Late abstract submission deadline: 22 April 2025
Abstracts can only be submitted online.
Abstract Regulations
With the submission of a late abstract to the EACR Annual Congress 2025, the submitting
author/presenting author:
- Accepts responsibility for the accuracy of the submitted abstract.
- Confirms that all co-authors are aware of and agree to the content of the abstract and support the
data presented.
- Warrants that the data and conclusions presented in the abstract have not been published in the
same format and with the same title prior to the date of the Congress.
- Identifies any financial interest in products or processes described in the abstract. This information
is to be forwarded to the Scientific Committee together with the abstract.
- States that, for studies involving human or animal subjects, permission has been obtained from the
relevant regulatory authority and properly informed consent given where appropriate.
- Gives permission for the abstract to be published by the European Association for Cancer Research
(EACR) on the Congress website and through the Congress app. Abstracts submitted during the late
abstract period (10-22 April) will NOT be published in an online supplement to the journal
Molecular Oncology.
Presentation of abstracts: All abstracts submitted during the late abstract period (10-22 April), are not
eligible for oral or spotlight presentation. All abstracts selected for poster presentation at the EACR 2025
Congress must be presented in person.
The submitting author for each abstract must designate a presenter who agrees to register for the
Congress and present in detail the research discussed in the abstract. We strongly advise that presenting
authors put funding and/or visa arrangements in place as early as possible to avoid disappointment.
Please note that the early rate registration deadline will NOT be extended for late abstract submitters, so to
take advantage of a cheaper registration, the presenter will need to register and pay by 28 April.
If the assigned presenter cannot attend the Congress, the authors are expected to designate a replacement
or withdraw the abstract no later than 16 May 2025.
If by 16 May 2025 the presenting author of the abstract is not registered the abstract will be withdrawn
from the programme.
